IM Cannabis (IMCC) Common Equity (2019 - 2026)

IM Cannabis' Common Equity history runs 8 years deep, the most recent figure standing at -$3.7 million for Q1 2026.

• In Q1 2026, Common Equity fell 268.97% year-over-year to -$3.7 million; the TTM figure through Mar 2026 stood at -$3.7 million (down 268.97% YoY), while the FY2025 annual figure was -$2.6 million, down 167.69% from the prior year.
• Common Equity was -$3.7 million for Q1 2026 at IM Cannabis, down from -$2.6 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $156.6 million in Q1 2022 to a low of -$3.7 million in Q1 2026.
• Historically, Common Equity has averaged $25.6 million across 5 years, with a median of $6.2 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Common Equity grew 1.31% in 2025, then tumbled 268.97% in 2026.
• A 5-year view of Common Equity shows it stood at $16.7 million in 2022, then tumbled by 39.7% to $10.1 million in 2023, then slumped by 62.7% to $3.8 million in 2024, then slumped by 169.07% to -$2.6 million in 2025, then tumbled by 44.14% to -$3.7 million in 2026.
• The last three Common Equity figures came in at -$3.7 million (Q1 2026), -$2.6 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.